These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus. Pratap B; Abraham G; Srinivas CN; Bhaskar S Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin. Boctor FN Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275 [TBL] [Abstract][Full Text] [Related]
7. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus. Abraham KA; Little MA; Dorman AM; Walshe JJ Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243 [TBL] [Abstract][Full Text] [Related]
8. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report. Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650 [No Abstract] [Full Text] [Related]
9. Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation. Parissis H; Gould K; Dark J J Cardiothorac Surg; 2010 Sep; 5():70. PubMed ID: 20813025 [TBL] [Abstract][Full Text] [Related]
10. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. Schmidt RJ; Venkat KK; Dumler F Transplant Proc; 1991 Dec; 23(6):3156-7. PubMed ID: 1721390 [No Abstract] [Full Text] [Related]
11. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient. Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824 [No Abstract] [Full Text] [Related]
12. [Hemolytic uremic syndrome due to sirolimus in a heart transplant recipient. Case report]. Izquierdo MT; Almenar L; Martínez-Dolz L; Moro JA Rev Esp Cardiol; 2007 Jan; 60(1):85-6. PubMed ID: 17288963 [No Abstract] [Full Text] [Related]
16. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period]. Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059 [TBL] [Abstract][Full Text] [Related]
18. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. Kaufman DB; Kaplan B; Kanwar YS; Abecassis M; Stuart FP Transplantation; 1995 Jun; 59(12):1737-9. PubMed ID: 7541579 [No Abstract] [Full Text] [Related]
19. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. McCauley J; Bronsther O; Fung J; Todo S; Starzl TE Lancet; 1989 Dec 23-30; 2(8678-8679):1516. PubMed ID: 2481200 [No Abstract] [Full Text] [Related]
20. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]